These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1703215)

  • 41. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
    Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epitope analysis of the T cell response to a complex antigen: proliferative responses to human rhinovirus capsids.
    Hastings GZ; Francis MJ; Rowlands DJ; Chain BM
    Eur J Immunol; 1993 Sep; 23(9):2300-5. PubMed ID: 7690329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subunit interaction in B19 parvovirus empty capsids.
    Rosenfeld SJ; Young NS; Alling D; Ayub J; Saxinger C
    Arch Virol; 1994; 136(1-2):9-18. PubMed ID: 7516147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a new neutralization antigenic site on poliovirus coat protein VP2.
    Emini EA; Jameson BA; Wimmer E
    J Virol; 1984 Nov; 52(2):719-21. PubMed ID: 6208380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface.
    Langeveld JP; Casal JI; Vela C; Dalsgaard K; Smale SH; Puijk WC; Meloen RH
    J Virol; 1993 Feb; 67(2):765-72. PubMed ID: 7678305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A protective anti-peptide antibody against the immunodominant site of the A24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence.
    Barnett PV; Pullen L; Staple RF; Lee LJ; Butcher R; Parkinson D; Doel TR
    J Gen Virol; 1996 May; 77 ( Pt 5)():1011-8. PubMed ID: 8609466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
    Smith TJ; Chase ES; Schmidt TJ; Olson NH; Baker TS
    Nature; 1996 Sep; 383(6598):350-4. PubMed ID: 8848050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of two novel BTV16-specific B cell epitopes using monoclonal antibodies against the VP2 protein.
    Wang WS; Sun EC; Xu QY; Yang T; Qin YL; Zhao J; Feng YF; Li JP; Wei P; Zhang CY; Wu DL
    Appl Microbiol Biotechnol; 2013 Jul; 97(13):5933-42. PubMed ID: 23467824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of Mengo virus T helper cell epitopes.
    Muir S; Kobasa D; Bittle J; Scraba D
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2925-36. PubMed ID: 7525861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-idiotypic antibody specific for an infectious bursal disease virus-neutralizing monoclonal antibody does not interfere with the virus infection.
    Yamaguchi T; Igusa A; Setiyono A; Fukushi H; Hirai K
    Arch Virol; 2002 Oct; 147(10):2017-23. PubMed ID: 12376762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different rhinovirus serotypes neutralized by antipeptide antibodies.
    McCray J; Werner G
    Nature; 1987 Oct 22-28; 329(6141):736-8. PubMed ID: 2444889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus.
    Schnitzler D; Bernstein F; Müller H; Becht H
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1563-71. PubMed ID: 7688411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants.
    Kanno T; Inoue T; Wang Y; Sarai A; Yamaguchi S
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3099-106. PubMed ID: 8847515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multiply substituted G-H loop from foot-and-mouth disease virus in complex with a neutralizing antibody: a role for water molecules.
    Ochoa WF; Kalko SG; Mateu MG; Gomes P; Andreu D; Domingo E; Fita I; Verdaguer N
    J Gen Virol; 2000 Jun; 81(Pt 6):1495-505. PubMed ID: 10811933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neutralizing antibody to Mengo virus, induced by synthetic peptides.
    Muir S; Weintraub JP; Hogle J; Bittle JL
    J Gen Virol; 1991 May; 72 ( Pt 5)():1087-92. PubMed ID: 1709682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli.
    Lounsbach GR; Bourgeois C; West WH; Robinson JW; Carter MJ; Toms GL
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2559-65. PubMed ID: 7506297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization.
    Katpally U; Fu TM; Freed DC; Casimiro DR; Smith TJ
    J Virol; 2009 Jul; 83(14):7040-8. PubMed ID: 19403680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of conformational neutralizing epitopes on the capsid protein of canine calicivirus.
    Matsuura Y; Tohya Y; Mochizuki M; Takase K; Sugimura T
    J Gen Virol; 2001 Jul; 82(Pt 7):1695-1702. PubMed ID: 11413381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-based identification of a major neutralizing site in an adenovirus hexon.
    Pichla-Gollon SL; Drinker M; Zhou X; Xue F; Rux JJ; Gao GP; Wilson JM; Ertl HC; Burnett RM; Bergelson JM
    J Virol; 2007 Feb; 81(4):1680-9. PubMed ID: 17108028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.